QRISK3 Tool Predicts Thrombotic Events in ET, PV
The QRISK3 assessment is designed for the general population, but it appears to also have utility in patients with essential thrombosis and polycythemia vera.
Previous Post
NeurologyLive® Friday 5 — August 8, 2025
Next Post
HHS cites list of studies as scientific justification for cancellation of mRNA vaccine contracts
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago